Skip to main content

CSIRO Licenses RNAi Technology to Bayer CropScience

NEW YORK, April 27 (GenomeWeb News) - Australia's Commonwealth Scientific and Industrial Research Organization (CSIRO) announced yesterday that it has agreed to license its DNA-delivered RNAi gene-silencing technology to Bayer CropScience.

 

CSIRO said that Bayer will develop, market, and sell selected crop plant varieties incorporating the RNAi technology, which can be used to introduce disease resistance, enhance nutritional qualities, and control flowering by removing unwanted gene functions.

 

This marks the first deal between Canberra-based CSIRO and a major agri-biotechnology company, the organization said.

The Scan

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.